טוען...
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants
The severity of symptoms as well as efficacy of antidepressants in major depressive disorder (MDD) is modified by single nucleotide polymorphisms (SNPs) in different genes, which may contribute in an additive or synergistic fashion. We aimed to investigate depression severity in participants with MD...
שמור ב:
| הוצא לאור ב: | Drug Dev Res |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Inc.
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7028038/ https://ncbi.nlm.nih.gov/pubmed/31617956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21609 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|